The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression
Abstract
Oxidative stress accompanies angiotensin (ANG) II infusion, but the role of ANG type 1 vs. type 2 receptors (AT 1-R and AT 2-R, respectively) is unknown. We infused ANG II subcutaneously in rats for 1 wk. Excretion of 8-isoprostaglandin F 2α(8-Iso) and malonyldialdehyde (MDA) were related to renal cortical mRNA abundance for subunits of NADPH oxidase and superoxide dismutases (SODs) using real-time PCR. Subsets of ANG II-infused rats were given the AT 1-R antagonist candesartan cilexetil (Cand) or the AT 2-R antagonist PD-123,319 (PD). Compared to vehicle (Veh), ANG II increased 8-Iso excretion by 41% (Veh, 5.4 ± 0.8 vs. ANG II, 7.6 ± 0.5 pg/24 h; P < 0.05). This was prevented by Cand (5.6 ± 0.5 pg/24 h; P < 0.05) and increased by PD (15.8 ± 2.0 pg/24 h; P < 0.005). There were similar changes in MDA excretion. Compared to Veh, ANG II significantly ( P < 0.005) increased the renal cortical mRNA expression of p22 phox(twofold), Nox-1 (2.6-fold), and Mn-SOD (1.5-fold) and decreased expression of Nox-4 (2.1-fold) and extracellular (EC)-SOD (2.1-fold). Cand prevented all of these changes except for the increase in Mn-SOD. PD accentuated changes in p22 phox and Nox-1 and increased p67 phox. We conclude that ANG II infusion stimulates oxidative stress via AT 1-R, which increases the renal cortical mRNA expression of p22 phox and Nox-1 and reduces abundance of Nox-4 and EC-SOD. This is offset by strong protective effects of AT 2-R, which are accompanied by decreased expression of p22 phox, Nox-1, and p67 phox.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Babior, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,134
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Winer, J., Jung, C. K. S., Shackel, I., & Williams, P. M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4085 · Cited by 1,387
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
Roberts, L. J., & Morrow, J. D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00264-6 · Cited by 996
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Identification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 842
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension
Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A., & Harrison, D. G. (1997) · Circulation · doi:10.1161/01.cir.95.3.588 · Cited by 823
Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000012569.55432.02 · Cited by 676
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training
Fukai, T., Siegfried, M. R., Ushio-Fukai, M., Cheng, Y., Kojda, G., & Harrison, D. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9551 · Cited by 563
p22phox mRNA Expression and NADPH Oxidase Activity Are Increased in Aortas From Hypertensive Rats
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., & Griendling, K. K. (1997) · Circulation Research · doi:10.1161/01.res.80.1.45 · Cited by 553
Pagano, P. J., Clark, J. K., Cifuentes-Pagano, M. E., Clark, S. M., Callis, G. M., & Quinn, M. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14483 · Cited by 455
Expression of phagocyte NADPH oxidase components in human endothelial cells
Jones, S. A., O'Donnell, V. B., Wood, J. D., Broughton, J. P., Hughes, E. J., & Jones, O. T. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.4.h1626 · Cited by 426
Chabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., & Wilcox, C. S. (2002) · Hypertension · doi:10.1161/hy0202.103264 · Cited by 377
Self-citationSchnackenberg, C. G., & Wilcox, C. S. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.424 · Cited by 375
Self-citationReactive oxygen species: Roles in blood pressure and kidney function
Wilcox, C. S. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0041-2 · Cited by 341
Self-citationHornig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S., Christoph, A., Tatge, H., & Drexler, H. (2001) · Circulation · doi:10.1161/01.cir.103.6.799 · Cited by 341
Siragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314
Increased Oxidative Stress in Experimental Renovascular Hypertension
Lerman, L. O., Nath, K. A., Rodriguez-Porcel, M., Krier, J. D., Schwartz, R. S., Napoli, C., & Romero, J. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.541 · Cited by 271
Distribution of angiotensin AT1and AT2receptor subtypes in the rat kidney
Miyata, N., Park, F., Li, X. F., & Cowley, A. W. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f437 · Cited by 270
Wingler, K., Wünsch, S., Kreutz, R., Rothermund, L., Paul, M., & Schmidt, H. H. H. W. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00727-4 · Cited by 269
Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Pagano, P. J., Chanock, S. J., Siwik, D. A., Colucci, W. S., & Clark, J. K. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.331 · Cited by 229
Thrasher, A. J., Keep, N. H., Wientjes, F., & Segal, A. W. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90100-7 · Cited by 219
A Mouse Model of Angiotensin II Slow Pressor Response: Role of Oxidative Stress
Kawada, N., Imai, E., Karber, A., Welch, W. J., & Wilcox, C. S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000035087.11758.ed · Cited by 195
Self-citationModulation of Extracellular Superoxide Dismutase Expression by Angiotensin II and Hypertension
Fukai, T., Siegfried, M. R., Ushio-Fukai, M., Griendling, K. K., & Harrison, D. G. (1999) · Circulation Research · doi:10.1161/01.res.85.1.23 · Cited by 190
Generation of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Upregulation of p67phoxand gp91phoxin aortas from angiotensin II-infused mice
Cifuentes, M. E., Rey, F. E., Carretero, O. A., & Pagano, P. J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2234 · Cited by 169
Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II–Infused Hypertensive Rats
Nishiyama, A., Fukui, T., Fujisawa, Y., Rahman, M., Tian, R., Kimura, S., & Abe, Y. (2001) · Hypertension · doi:10.1161/01.hyp.37.1.77 · Cited by 147
Mervaala, E. M. A., Cheng, Z. J., Tikkanen, I. T., Lapatto, R., Nurminen, K., Vapaatalo, H., Müller, D. N., Fiebeler, A., Ganten, U., Ganten, D., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.414 · Cited by 135
Differential role of angiotensin II receptor subtypes on endothelial superoxide formation
Sohn, H. Y., Raff, U., Hoffmann, A., GLOE, T. R., Heermeier, K., Galle, J., & Pohl, U. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703566 · Cited by 122
AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR
Welch, W. J., & Wilcox, C. S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041257.x · Cited by 115
Self-citationCross, A. R., & Curnutte, J. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6543 · Cited by 105
Dobrian, A. D., Schriver, S. D., & Prewitt, R. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.361 · Cited by 104
Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension
Barton, C. H., Ni, Z., & Vaziri, N. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031083.x · Cited by 100
Effects of AT 1 and AT 2 Angiotensin Receptor Antagonists in Angiotensin II-Infused Rats
Li, J. S., Touyz, R. M., & Schiffrin, E. L. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.487 · Cited by 93
Subpressor Doses of Angiotensin II Increase Plasma F 2 -Isoprostanes in Rats
Reckelhoff, J. F., Zhang, H., Srivastava, K., Roberts, L. J., Morrow, J. D., & Romero, J. C. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.476 · Cited by 88
Klein, T., Reutter, F., Schweer, H., et al. (1997) · PubMed · Cited by 85
Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal Hemodynamics
Deng, X., Welch, W. J., & Wilcox, C. S. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1173 · Cited by 73
Self-citationCyclooxygenase‐Dependent Formation of the Isoprostane 8‐EPI Prostaglandin F2αa
Praticò, D., Lawson, J. A., & FitzGerald, G. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb52730.x · Cited by 66
Generation of the Isoprostane 8-Epi-prostaglandin F2α In Vitro and In Vivo via the Cyclooxygenases
Klein, T., Reutter, F., Schweer, H., Seyberth, H. W., & Nüsing, R. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36968-x · Cited by 43
INCREASED OXIDATIVE DNA DAMAGE IN STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS
Negishi, H., Ikeda, K., Sagara, M., Sawamura, M., & Yamori, Y. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03055.x · Cited by 41
Up-regulation of Angiotensin Type 2 Receptor mRNA by Angiotensin II in Rat Cortical Cells
Shibata, K., Makino, I., Shibaguchi, H., Niwa, M., Katsuragi, T., & Furukawa, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7521 · Cited by 38
Klein, T., Neuhaus, K., Reutter, F., & Nüsing, R. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704111 · Cited by 33
Cited by
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
Renal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
Self-citationOxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Wilcox, C. S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00250.2005 · Cited by 481
Self-citation
Metadata
- Authors
- Chabrashvili, T., Kitiyakara, C., Blau, J., Karber, A., Aslam, S., Welch, W. J., & Wilcox, C. S.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2003-07
- Volume
- 285
- Issue
- 1
- Pages
- R117-R124
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2137737171
- Cited by
- 323
- References
- 50
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.